UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

Pamela Bjorkman of the California Institute of Technology won the prize for ‘offering new hope in the fight against ...

Researchers reveal new insights into the how the matrix layer of HIV-1 becomes matureResearchers from the Max Planck ...

Researchers from the Max Planck Institute of Biochemistry have discovered the mechanism behind an important step in the life ...

This fundamental manuscript comprehensively examines the roles of nine structural proteins in herpes simplex virus 1 (HSV-1) assembly and nuclear egress. By integrating cryo-light microscopy and soft ...

HIV and syphilis affect similar patient groups and coinfection ... must have investigations aimed at direct identification of the organism—ie, dark-field microscopy of material from lesions or by ...

Antiretroviral drugs are used to treat HIV infection. They work by blocking a stage of the virus's life cycle and, by doing so, prevent the virus from replicating. The drugs are organized into six ...

US President Donald Trump’s recent executive order to freeze USAID’s funding means Nyumbani’s access to life-saving antiretroviral drugs, which stop the HIV virus from replicating in the ...